The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


NORLEVO® 1.5 mg tablet



Laboratoire HRA PharmaPA1166/002/001

Main Information

Trade NameNORLEVO® 1.5 mg tablet
Active SubstancesLevonorgestrel
Dosage FormTablet
Licence HolderLaboratoire HRA Pharma
Licence NumberPA1166/002/001

Group Information

ATC CodeG03AD Emergency contraceptives
G03AD01 levonorgestrel

Status

License statusAuthorised
Licence Issued26/08/2005
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back